RT Journal Article
SR Electronic
T1 Genomic risk prediction for breast cancer in older women
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.05.03.21256567
DO 10.1101/2021.05.03.21256567
A1 Lacaze, Paul
A1 Bakshi, Andrew
A1 Riaz, Moeen
A1 Orchard, Suzanne G
A1 Tiller, Jane
A1 Neumann, Johannes T
A1 Carr, Prudence R
A1 Joshi, Amit D
A1 Cao, Yin
A1 Warner, Erica T
A1 Manning, Alisa
A1 Nguyen-Dumont, Tú
A1 Southey, Melissa C.
A1 Milne, Roger L
A1 Ford, Leslie
A1 Sebra, Robert
A1 Schadt, Eric
A1 Gately, Lucy
A1 Gibbs, Peter
A1 Thompson, Bryony A
A1 Macrae, Finlay A
A1 James, Paul
A1 Winship, Ingrid
A1 McLean, Catriona
A1 Zalcberg, John R
A1 Woods, Robyn L
A1 Chan, Andrew T
A1 Murray, Anne M
A1 McNeil, John J
YR 2021
UL http://medrxiv.org/content/early/2021/05/05/2021.05.03.21256567.abstract
AB Background Genomic risk prediction models for breast cancer (BC) have been predominantly developed with data from women aged less than 70 years. Prospective studies of women aged 70 years or older have been limited.Methods We assessed the effect of a 313-variant polygenic risk score (PRS) for BC in 6,339 women of European ancestry aged ≥70 years. We evaluated incident BC diagnoses over a median follow-up of 4.7 years. A multivariable Cox regression model including conventional risk factors was applied to prospective data, and re-evaluated after adding the PRS. We also assessed the association of rare pathogenic variants (PVs) with BC in susceptibility genes (BRCA1/BRCA2/PALB2/CHEK2/ATM).Results The PRS, as a continuous variable, was an independent predictor of incident BC (hazard ratio [HR] per standard deviation (SD)=1.4, 95% confidence interval [CI] 1.3-1.6, N=110 cases) and hormone receptor (ER/PR)-positive disease (HR=1.5 [CI 1.2-1.9], N=79 cases). Women in the top quintile of the PRS distribution had higher risk of BC than women in the lowest quintile (HR=2.2 [CI 1.2-3.9]). The concordance index of the model without the PRS was 0.62 (95% CI 0.56-0.68) which improved after addition of the PRS to 0.65 (95% CI 0.59-0.71). Among 41 (0.6%) carriers of PVs in BC susceptibility genes, we observed no incident BC diagnoses.Conclusion The 313-variant PRS predicts BC risk in women aged 70 years and older.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT01038583Funding StatementThis work was supported by an ASPREE Flagship cluster grant (including the Commonwealth Scientific and Industrial Research Organisation, Monash University, Menzies Research Institute, Australian National University, University of Melbourne); and grants (U01AG029824 and U19AG062682) from the National Institute on Aging and the National Cancer Institute at the National Institutes of Health, by grants (334047 and 1127060) from the National Health and Medical Research Council of Australia, and by Monash University and the Victorian Cancer Agency. AEC receives a NHMRC Career Development Fellowship (1147843). HPS holds an NHMRC MRFF Next Generation Clinical Researchers Program Practitioner Fellowship (APP1137127). PL is supported by a National Heart Foundation Future Leader Fellowship.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study received local ethics committee approval from the Alfred Hospital Research Ethics CommitteeAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data underlying this article will be shared on reasonable request to the corresponding author.